EP1208069A1 - Process for catalyzing the oxidation of organic compounds - Google Patents
Process for catalyzing the oxidation of organic compoundsInfo
- Publication number
- EP1208069A1 EP1208069A1 EP00960420A EP00960420A EP1208069A1 EP 1208069 A1 EP1208069 A1 EP 1208069A1 EP 00960420 A EP00960420 A EP 00960420A EP 00960420 A EP00960420 A EP 00960420A EP 1208069 A1 EP1208069 A1 EP 1208069A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- solvent
- process according
- phase
- reaction medium
- inert aprotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000002894 organic compounds Chemical class 0.000 title claims abstract description 19
- 238000007254 oxidation reaction Methods 0.000 title claims abstract description 18
- 230000003647 oxidation Effects 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims description 46
- 239000000010 aprotic solvent Substances 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims description 39
- 239000006184 cosolvent Substances 0.000 claims description 25
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 claims description 23
- 239000007800 oxidant agent Substances 0.000 claims description 20
- 239000012429 reaction media Substances 0.000 claims description 11
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 9
- 239000003444 phase transfer catalyst Substances 0.000 claims description 7
- 239000012071 phase Substances 0.000 claims description 5
- 239000000376 reactant Substances 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 5
- 230000002051 biphasic effect Effects 0.000 claims description 4
- 239000003849 aromatic solvent Substances 0.000 claims description 3
- 125000003118 aryl group Polymers 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- 150000005621 tetraalkylammonium salts Chemical group 0.000 claims description 3
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical group OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 claims description 2
- 125000001931 aliphatic group Polymers 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 230000000269 nucleophilic effect Effects 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims 1
- XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical group [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 description 31
- 239000000460 chlorine Substances 0.000 description 17
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 16
- 230000001590 oxidative effect Effects 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 239000011572 manganese Substances 0.000 description 10
- 239000007858 starting material Substances 0.000 description 10
- 229910052801 chlorine Inorganic materials 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 125000001309 chloro group Chemical group Cl* 0.000 description 7
- 150000002431 hydrogen Chemical class 0.000 description 7
- -1 2,6-dichlorophenyl Chemical group 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229960003529 diazepam Drugs 0.000 description 6
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 6
- 229960002640 nordazepam Drugs 0.000 description 6
- FPRDNGOSKVGXHA-UHFFFAOYSA-N 7-chloro-1-methyl-4-oxido-5-phenyl-3h-1,4-benzodiazepin-4-ium-2-one Chemical compound [O-][N+]=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 FPRDNGOSKVGXHA-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- JYJVVHFRSFVEJM-UHFFFAOYSA-N iodosobenzene Chemical compound O=IC1=CC=CC=C1 JYJVVHFRSFVEJM-UHFFFAOYSA-N 0.000 description 5
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 229910052748 manganese Inorganic materials 0.000 description 4
- AKPLHCDWDRPJGD-UHFFFAOYSA-N nordazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)CN=C1C1=CC=CC=C1 AKPLHCDWDRPJGD-UHFFFAOYSA-N 0.000 description 4
- ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 description 4
- PBKONEOXTCPAFI-UHFFFAOYSA-N 1,2,4-trichlorobenzene Chemical compound ClC1=CC=C(Cl)C(Cl)=C1 PBKONEOXTCPAFI-UHFFFAOYSA-N 0.000 description 3
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 3
- JSTXCWJWQKRPIU-UHFFFAOYSA-N 6-chloro-1-methyl-4-phenylquinazolin-2-one Chemical compound N=1C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 JSTXCWJWQKRPIU-UHFFFAOYSA-N 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 229960004535 oxazepam Drugs 0.000 description 3
- 239000011877 solvent mixture Substances 0.000 description 3
- 229960003188 temazepam Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000012425 OXONE® Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000006575 electron-withdrawing group Chemical group 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000004783 oxidative metabolism Effects 0.000 description 2
- HJKYXKSLRZKNSI-UHFFFAOYSA-I pentapotassium;hydrogen sulfate;oxido sulfate;sulfuric acid Chemical compound [K+].[K+].[K+].[K+].[K+].OS([O-])(=O)=O.[O-]S([O-])(=O)=O.OS(=O)(=O)O[O-].OS(=O)(=O)O[O-] HJKYXKSLRZKNSI-UHFFFAOYSA-I 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- ASLWPAWFJZFCKF-UHFFFAOYSA-N tris(1,3-dichloropropan-2-yl) phosphate Chemical compound ClCC(CCl)OP(=O)(OC(CCl)CCl)OC(CCl)CCl ASLWPAWFJZFCKF-UHFFFAOYSA-N 0.000 description 2
- WACNXHCZHTVBJM-UHFFFAOYSA-N 1,2,3,4,5-pentafluorobenzene Chemical compound FC1=CC(F)=C(F)C(F)=C1F WACNXHCZHTVBJM-UHFFFAOYSA-N 0.000 description 1
- KGWVFQAPOGAVRF-UHFFFAOYSA-N 1-hexylimidazole Chemical compound CCCCCCN1C=CN=C1 KGWVFQAPOGAVRF-UHFFFAOYSA-N 0.000 description 1
- UUIMDJFBHNDZOW-UHFFFAOYSA-N 2-tert-butylpyridine Chemical compound CC(C)(C)C1=CC=CC=N1 UUIMDJFBHNDZOW-UHFFFAOYSA-N 0.000 description 1
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 1
- DBKIXSRJBMRMMF-UHFFFAOYSA-N 6-chloro-4-phenyl-1h-quinazolin-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)N=C1C1=CC=CC=C1 DBKIXSRJBMRMMF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 101710198130 NADPH-cytochrome P450 reductase Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003426 co-catalyst Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 150000003278 haem Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002443 hydroxylamines Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- USSBDBZGEDUBHE-UHFFFAOYSA-L magnesium;2-oxidooxycarbonylbenzoate Chemical compound [Mg+2].[O-]OC(=O)C1=CC=CC=C1C([O-])=O USSBDBZGEDUBHE-UHFFFAOYSA-L 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 150000002832 nitroso derivatives Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- MCZDHTKJGDCTAE-UHFFFAOYSA-M tetrabutylazanium;acetate Chemical compound CC([O-])=O.CCCC[N+](CCCC)(CCCC)CCCC MCZDHTKJGDCTAE-UHFFFAOYSA-M 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B33/00—Oxidation in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B41/00—Formation or introduction of functional groups containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C07D239/82—Oxygen atoms with an aryl radical attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
Definitions
- Synthetic metalloporphyrins can serve favorably to mimic oxidative catalytic reactions occurring in biological systems, with the aim of producing and identifying oxidative products of drug candidates, in quantities allowing in vivo studies.
- PCT application WO 96/08455 discloses a process for the preparation of oxidative products using various combinations of a synthetic metallopo ⁇ hyrin, a co-oxidizing reagent, and a solvent.
- the solvent is generally a CH3CN/CH2CI2 combination.
- the inventor has unexpectedly found that the yields of oxidative reactions involving metalloporphyrins and which can be useful for the synthesis of metabolites of organic compounds of interest could be increased in a substantial manner through the use of an inert aprotic solvent.
- one of the objects of the present invention is a process for the oxidation of organic compounds.
- This process comprises reacting the selected organic compound with catalytic amounts of a metalloporphyrin and of an oxidizing agent in the presence of an inert aprotic solvent and recovering the desired products obtained therefrom.
- the process of the invention is extremely useful in pharmaceutical research and development as it can be used to perform preliminary evaluations of the metabolic processes which are likely to occur when a given compound is tested in vivo. These preliminary evaluations can be performed rapidly without having to carry out expensive and time consuming in vivo experiments.
- the process of the present invention provides better yields of individual products than those obtained using prior art processes. In other words, the process of the present invention opens the possibility of obtaining and analyzing in a more systematic fashion a higher number of individual potential metabolites for a given selected compound on which the process is carried out.
- the present invention therefore concerns a process for the efficient oxidative preparation of metabolites of organic compounds.
- the invention comprises reacting an organic compound of interest with a catalytic amount of a metalloporphyrin and an oxidizing agent, in a non-reactive aprotic solvent. It also comprises recovering and identifying the desired reaction products.
- compounds containing heteroatoms can be efficiently oxidized through the process of the invention, particularly to a higher oxidation state, and more particularly to their highest oxidation state.
- heteroatoms such as nitrogen or sulfur
- primary amines can be readily converted to their corresponding hydroxylamines, nitroso- or nitro- derivatives; and tertiary amines to their corresponding N-oxides.
- C-H bonds can be conveniently hydroxylated into C-OH bonds by metallopo ⁇ hyrin- catalyzed oxidations according to this invention.
- Examples include labile C-H bonds, such as those in benzylic positions or C-H bonds wherein the carbon atom is adjacent to a heteroatom (e.g. N, S, O, or the like). Those are particularly reactive to these conditions.
- primary alcohols can be converted to their corresponding aldehydes; in turn aldehydes can be converted to their corresponding acids, and said acids may further undergo decarboxylation.
- Carbon-carbon double bonds can be epoxidized by metallopo ⁇ hyrin-catalyzed oxidation according to this invention, and aromatic groups can be oxidized into corresponding phenols or quinones.
- the main parameters involved in the process of the invention are the starting material which is usually an organic compound of interest, the reactants which usually include a metallopo ⁇ hyrin, an oxidizing agent and an inert aprotic solvent, and the reaction conditions which comprise the reaction temperature and the reaction time.
- the starting material which is usually an organic compound of interest
- the reactants which usually include a metallopo ⁇ hyrin, an oxidizing agent and an inert aprotic solvent
- reaction conditions which comprise the reaction temperature and the reaction time.
- metallopo ⁇ hyrins are described in international patent application WO 96/08455.
- the term "metallopo ⁇ hyrin”, as used herein, refers to po ⁇ hyrin compounds of formula (I):
- Rl, R2 and R3 independently represent hydrogen or an electron- withdrawing group such as Cl, F, Br, SO3Na, or the like,
- R4, R5, R6, R7, R8, R9, RIO and Rl l independently represent hydrogen or an electron-withdrawing group such as Cl, F, Br, NO2, CN, SO3Na or the like,
- R12 is Cl, acetate or the like
- M is selected from the group consisting of iron, manganese, chromiirai, ruthenium, cobalt, copper and nickel.
- Preferred metallopo ⁇ hyrins include tetrakis(pentafluoro-phenyl)po ⁇ hyrin Mn(I_3) chloride, herein abbreviated as Mn(TPFPP)Cl, which is the compound of formula (I) above wherein M is manganese, Rl, R2 and R3 are fluorine, R4, R5, R6, R7, R8. R9, RIO and Rl 1 are hydrogen, and R12 is chlorine.
- Preferred metallopo ⁇ hyrins also include: tetrakis(pentafluoro-phenyl)po ⁇ hyrin Fe chloride, abbreviated as Fe(TPFPP)Cl, which is the compound of formula (I) above wherein M is iron, Rl, R2 and R3 are fluorine, R4, R5, R6, R7, R8, R9, RIO and Rl 1 are hydrogen, and R12 is chlorine;
- Mn(TDCPP)Cl tetrakis(2,6-dichlorophenyl)po ⁇ hyrin Mn chloride, abbreviated as Mn(TDCPP)Cl, which is the compound of formula (I) above wherein M is manganese, Rl is chloride, R2, R3, R4, R5, R6, R7, R8, R9, RIO and Rl 1 are hydrogen, and R12 is chlorine;
- Fe(TDCPP)Cl tetrakis(2,6-dichlorophenyl)po ⁇ hyrin Fe chloride, abbreviated as Fe(TDCPP)Cl, which is the compound of formula (I) above wherein M is iron, Rl is chloride, R2, R3, R4, R5, R6, R7, R8, R9, RIO and Rl 1 are hydrogen, and R12 is chlorine;
- Fe tetrakis(2,6-dichlorophenyl)-octachloropo ⁇ hyrin chloride
- Fe(TDCPClgP)Cl which is the compound of formula (I) above wherein M is iron, Rl is chloride, R2 and R3 are hydrogen, R4, R5, R6, R7, R8, R9, RIO and Rl 1 are chloride, and R12 is chlorine;
- the amount of the metallopo ⁇ hyrin catalyst usually ranges between 0.5 and 10 % molar and is preferably about 1 % molar.
- Oxidizing agents Various oxidizing agents can be used in the instant invention. It should be noted that the very nature of the oxidizing agent does not appear to be a limiting factor in the process of the present invention. The person skilled in the art can thus select the appropriate oxidizing agent among the wide variety of compounds which have been used in metallopo ⁇ hyrin- catalyzed oxidative reactions.
- a list of possible agents includes, but is not limited to: iodosylbenzene, also known as iodosobenzene, aqueous solutions of hydrogen peroxide (concentration about 30 to 45 %), anhydrous equivalents of hydrogen peroxide such as sodium percarbonate, urea hydrogen peroxide complex or the like, potassium monopersulfate, sodium hypochlorite, tert-butyl hydroperoxide, cumene hydroperoxide, m- chloroperbenzoic acid, and magnesium monoperoxyphthalate.
- Preferred oxidants include iodosylbenzene, any source of hydrogen peroxide, and potassium monopersulfate.
- Oxidation using hydrogen peroxide is more efficient in the presence of a co-catalyst such as imidazole, ammonium acetate, N-hexylimidazole, amine N-oxides, tetrabutylammonium acetate, tert-butyl pyridine, pyridine, 4-methylpyridine, and 2,4,6-trimethyl-pyridine.
- a co-catalyst such as imidazole, ammonium acetate, N-hexylimidazole, amine N-oxides, tetrabutylammonium acetate, tert-butyl pyridine, pyridine, 4-methylpyridine, and 2,4,6-trimethyl-pyridine.
- the metallopo ⁇ hyrin-catalyzed oxidation of the invention is performed in an inert solvent, which in fact can contain one or several solvents.
- the term 'inert aprotic solvent' when used herein, is intended to designate any solvent or any mixture of solvents which, when evaluated in a global manner, does not react in any substantial fashion with the starting materials or with the products of the reaction. More particularly, the solvent should not react with the oxidizing agent. Furthermore, the solvent should be resistant to hydrogen abstraction.
- this mixture usually contains a so-called “main solvent” and a “co-solvent”. It should be noted however that several solvents having similar properties could be used to form the main solvent. Similar considerations apply to an eventual mixture of co-solvents.
- the main solvent is present in larger amounts in the solvent mixture than the co-solvent.
- the main solvent should therefore be inert and aprotic.
- the main solvent should have the capability to dissolve the starting material (i.e. the organic compound of interest) and the metallopo ⁇ hyrin.
- the main solvent examples include, but are not limited to polyhalogenated aliphatic solvents such as l,l,2-trichloro-l,2,2-trifluoroethane and the like or polyhalogenated aromatic solvents such as 1,2-dichlorobenzene, 1,2,4-trichlorobenzene, pentafluorobenzene and the like.
- Preferred polyhalogenated solvents include polyfluorinated aromatic compounds, such as trifluorotoluene (also known as benzotrifluoride) and the like. Trifluorotoluene is a most preferred solvent, which combines the capacity of dissolving a wide variety of organic compounds with a low reactivity towards oxidative conditions.
- suitable concentrations of starting material in the chosen solvent can vary between 0.1 M and 0.5 M, preferably 0.1 M.
- the co-solvent is present in small amounts in the mixture and is introduced to provide additional properties of interest to the overall solvent mixture, which will be useful at some point but which will not interfere in a significant manner with the reaction itself.
- a co-solvent can be used to improve its solubility in the reaction medium.
- a co-solvent can be used in order to improve its solubility in the reaction medium.
- Preferred co-solvents include highly polar and poorly nucleophilic co-solvents.
- the properties of the co-solvent should be chosen in order to minimize complex formation with the metallopo ⁇ hyrin.
- 2,2,2-Trifluoroethanol and, particularly, 1,1,1,3,3,3-hexafluoro- propan-2-ol also called hexafluoroisopropanol or HFIP are representative examples of co- solvents that can be used in the process of this invention.
- hexafluoroisopropanol can be useful in oxidation reactions performed with iodosylbenzene in one of the organic solvents mentioned above since this co-solvent helps dissolve this particular oxidant in the reaction medium.
- the amount of co-solvent used to dissolve the starting material or the oxidizing agent and eventually the catalyst should be kept to relatively low levels with respect to the main solvent.
- suitable concentrations can vary between 1 and 30%, preferably between 1 and 20% and more preferably between 1 and 10% with respect with the main solvent.
- the co-solvent can be used in order to facilitate transfer of reactants within the reaction medium.
- a co- solvent is used in the case where the starting material or one or several reactants leads to a reaction mixture which comprises a biphasic solution.
- the reaction is biphasic and a water-miscible co-solvent can be used to facilitate the transfer of the oxidant in the organic phase.
- a water-miscible co-solvent can be used to facilitate the transfer of the oxidant in the organic phase.
- a minimal amount of co-solvent such as hexafluoroisopropanol, is preferred. This co-solvent is miscible with water and it can facilitate dissolution of the starting material.
- the amount of co-solvent which should be used in this second embodiment usually ranges between 0.25 and 1 equivalent, preferably between 0.3 and 0.5 and is more preferably about 0.4 equivalent with respect to the starting material.
- a phase-transfer catalyst can be used to facilitate the transfer of any of the reactants into the phase where the reaction will take place.
- a phase-transfer catalyst can be used to facilitate the transfer of the oxidant in the organic phase.
- phase-transfer catalysts examples include tetraalkyl ammonium salts (such as dodecyl- trimethyl-am onium bromide and the like).
- the reaction is carried out at a temperature between about -20 °C and 100 °C, and preferably between about -10 °C and 40 °C.
- reaction rate is then preferably performed in an ultrasound bath cooled to 0°C.
- the duration of the reaction varies from a few minutes up to 2 h. Advancement can be monitored with TLC or HPLC analytical techniques; thus the reaction is stopped when the oxidation reaction reaches a plateau point beyond which no substantial conversion is observed.
- the mass spectra are recorded on a Micromass Platform LC spectrometer (simple quadrupole with positive ionization electrospray).
- the infrared spectra are recorded on a Nicolet spectrometer.
- flash chromatography on a silica column means a method adapted from that of Still et al. (1978) J. Org. Chem. 42: 2923. The purity of elution fractions is verified before they are gathered and evaporated.
- the terms “evaporation”, “elimination” or “concentration” of the solvents mean, possibly after desiccation on an appropriate dehydrating agent such as Na2SO4 or MgSO4, a distillation under a pressure of 25 to 50 mm Hg (3,3 to 6,7 kPa) with moderate heating in a water bath at a temperature below 30 °C.
- EXAMPLE 1 r.y.Hat.nn of ⁇ ..aTi am (1) with indosylbenzene (PhT ) catalysed by tetrakistpp ⁇ taflnnr ⁇ - ⁇ hpny1)pn ⁇ hyrin manganese (TTT) r/hlnri e in friflnnrntnlnpnp
- nordiazepam (2), temazepam (3), oxazepam (4), 6-chloro-4-phenyl-l- memyl-2-(l_ _ q ⁇ inazo_inone (5) and 6-chloro-4-phenyl-2-(lH)-quinazol_none (£) are formed.
- reaction is monitored by analytical ⁇ PLC one hour after each addition: a sample, prepared with 5 ⁇ L of crude and 100 ⁇ L of a 5 mM methanolic solution of acetophenone (internal standard) diluted with 395 ⁇ L of methanol, is injected into a Nucleosil 5C18 150x4.6 mm column eluting with 50/50 methanol/water at 1 mL/min during 45 minutes. Nordiazepam (2), temazepam (2), oxazepam (4) formed are identified by comparison with authentic samples (Sigma). Their retention times are respectively 21.9, 16.7 and 13.3 min.
- 6-Chloro-l-methyl-4-phenyl-lH-quinazolin-2-one (5) and 6-chloro-4-phenyl- lH-quinazolin-2-one (fi), respectively eluting at 25.1 and 20.5 min, are identified in a separate run by isolation and comparison of * ⁇ NMR and MS data with Felix et al (1968) J Heterocycl. Chem. 5, 731 and Sulkowski etal (1961) J. Org. Chem. 22, AA1A.
- nordiazepam (2), temazepam (2), oxazepam (4), 6-chloro-4-phenyl-l- methyl-2-(lH)-quinazolinone (5), diazepam N-oxide (2) and nordiazepam N-oxide (8) are formed.
- Diazepam N-oxide (2) (retention time 8.4 min) and nordiazepam N-oxide (8) (6.7 min) are identified by comparison with samples prepared from the reaction of diazepam and nordiazepam with m- chloroperbenzoic acid (cf. Ebel et al (1979) Arzneim.-Forsch. 22, 1317).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
Description
Claims
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14807999P | 1999-08-10 | 1999-08-10 | |
| US148079P | 1999-08-10 | ||
| US15010199P | 1999-08-20 | 1999-08-20 | |
| US150101P | 1999-08-20 | ||
| PCT/EP2000/007726 WO2001010797A1 (en) | 1999-08-10 | 2000-08-09 | Process for catalyzing the oxidation of organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1208069A1 true EP1208069A1 (en) | 2002-05-29 |
Family
ID=26845496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00960420A Withdrawn EP1208069A1 (en) | 1999-08-10 | 2000-08-09 | Process for catalyzing the oxidation of organic compounds |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1208069A1 (en) |
| JP (1) | JP2003506419A (en) |
| KR (1) | KR20020024323A (en) |
| CN (1) | CN1367769A (en) |
| AU (1) | AU776140B2 (en) |
| BR (1) | BR0013018A (en) |
| CA (1) | CA2380851A1 (en) |
| CZ (1) | CZ2002452A3 (en) |
| HK (1) | HK1047428A1 (en) |
| HU (1) | HUP0202521A2 (en) |
| IL (1) | IL147452A0 (en) |
| MX (1) | MXPA02001388A (en) |
| PL (1) | PL356156A1 (en) |
| RU (1) | RU2002103336A (en) |
| TR (1) | TR200200330T2 (en) |
| WO (1) | WO2001010797A1 (en) |
| YU (1) | YU4902A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2807032B1 (en) * | 2000-03-29 | 2003-04-18 | Warner Lambert Co | MODIFICATION OF CHEMOSLECTIVITY DURING THE OXIDATION OF NITROGEN ORGANIC COMPOUNDS |
| CN102503860A (en) * | 2011-11-14 | 2012-06-20 | 武汉大学 | Synthetic method of 1, 3-two substituted ureas and carbamate |
| PT107020B (en) * | 2013-06-21 | 2015-07-09 | Univ Aveiro | PROCESS FOR THE PRODUCTION OF INDIGO AND ITS DERIVATIVES |
| CN115197170A (en) * | 2021-04-09 | 2022-10-18 | 中国科学院上海有机化学研究所 | Method for preparing epoxy dodecane from cyclododecene |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1217608B (en) * | 1988-05-17 | 1990-03-30 | Istituto Guido Donegami Spa | PROCESS FOR THE PREPARATION OF EPOXY |
| DD291748A5 (en) * | 1990-02-01 | 1991-07-11 | Bitterfeld Chemie | PROCESS FOR PREPARING ALLYL HYDROXYLATED TERPENOIDES OF HYDROCARBONS |
| US5760216A (en) * | 1994-09-15 | 1998-06-02 | Abbott Laboratories | Use of synthetic metalloporphyrins for preparation and prediction of drug metabolites |
-
2000
- 2000-08-09 KR KR1020027001738A patent/KR20020024323A/en not_active Withdrawn
- 2000-08-09 HK HK02108574.5A patent/HK1047428A1/en unknown
- 2000-08-09 EP EP00960420A patent/EP1208069A1/en not_active Withdrawn
- 2000-08-09 AU AU72738/00A patent/AU776140B2/en not_active Ceased
- 2000-08-09 PL PL00356156A patent/PL356156A1/en not_active Application Discontinuation
- 2000-08-09 TR TR2002/00330T patent/TR200200330T2/en unknown
- 2000-08-09 CN CN00811067A patent/CN1367769A/en active Pending
- 2000-08-09 WO PCT/EP2000/007726 patent/WO2001010797A1/en not_active Ceased
- 2000-08-09 JP JP2001515270A patent/JP2003506419A/en active Pending
- 2000-08-09 IL IL14745200A patent/IL147452A0/en unknown
- 2000-08-09 CA CA002380851A patent/CA2380851A1/en not_active Abandoned
- 2000-08-09 YU YU4902A patent/YU4902A/en unknown
- 2000-08-09 BR BR0013018-4A patent/BR0013018A/en not_active IP Right Cessation
- 2000-08-09 MX MXPA02001388A patent/MXPA02001388A/en not_active Application Discontinuation
- 2000-08-09 HU HU0202521A patent/HUP0202521A2/en unknown
- 2000-08-09 CZ CZ2002452A patent/CZ2002452A3/en unknown
- 2000-08-09 RU RU2002103336/04A patent/RU2002103336A/en not_active Application Discontinuation
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0110797A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU7273800A (en) | 2001-03-05 |
| TR200200330T2 (en) | 2003-02-21 |
| CN1367769A (en) | 2002-09-04 |
| RU2002103336A (en) | 2003-09-20 |
| MXPA02001388A (en) | 2004-07-16 |
| YU4902A (en) | 2004-09-03 |
| CA2380851A1 (en) | 2001-02-15 |
| AU776140B2 (en) | 2004-08-26 |
| BR0013018A (en) | 2002-04-16 |
| IL147452A0 (en) | 2002-08-14 |
| WO2001010797A1 (en) | 2001-02-15 |
| KR20020024323A (en) | 2002-03-29 |
| JP2003506419A (en) | 2003-02-18 |
| HK1047428A1 (en) | 2003-02-21 |
| PL356156A1 (en) | 2004-06-14 |
| HUP0202521A2 (en) | 2002-10-28 |
| CZ2002452A3 (en) | 2002-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5373764B2 (en) | Novel opiate reduction using catalytic hydrogen transfer reaction | |
| Imada et al. | Flavin‐catalyzed oxidation of amines and sulfides with molecular oxygen: biomimetic green oxidation | |
| Largeron et al. | A Metalloenzyme‐Like Catalytic System for the Chemoselective Oxidative Cross‐Coupling of Primary Amines to Imines under Ambient Conditions | |
| Itoh et al. | Synthesis of 2-arylbenzothiazoles from 2-aminobenzenethiol and aryl aldehydes catalyzed by scandium triflate | |
| US6815543B1 (en) | Process for catalyzing the oxidation of organic compounds | |
| Kraïem et al. | Hydrogen peroxide/dimethyl carbonate: a green system for epoxidation of N-alkylimines and N-sulfonylimines. One-pot synthesis of N-alkyloxaziridines from N-alkylamines and (hetero) aromatic aldehydes | |
| Choukairi Afailal et al. | Dearomative syn-dihydroxylation of naphthalenes with a biomimetic iron catalyst | |
| Zhang et al. | Dearomatization reaction of β-naphthols with disulfurating reagents | |
| Park et al. | β‐Aminosulfonyl Fluorides via Water‐Accelerated N‐Heterocyclic Carbene Catalysis | |
| AU776140B2 (en) | Process for catalyzing the oxidation of organic compounds | |
| JPH07206865A (en) | New porphyrin and its synthesis from dipyrromethane compound and aldehyde | |
| JPH07206735A (en) | Oxidizing method for alkane with new porphyrin synthesized from dipyrromethane and aldehyde | |
| Choukairi Afailal et al. | Manganese‐Catalyzed Enantioselective Dearomative Epoxidation of Naphthalenes with Aqueous Hydrogen Peroxide | |
| Caputo et al. | Synthesis of α‐Imino Amidines and 2, 3‐Diamino Indolenines Using a One‐Pot Graphene Oxide‐Catalyzed Process | |
| Kang et al. | Silver-catalyzed cross-dehydrogenative coupling of benzoxazine-2-ones with resorcinol | |
| Cai et al. | N-Aryl/heteroaryl oxaziridines: from photochemical synthesis to reactivity investigation in heteroatom transfer reactions | |
| WO2014152737A1 (en) | Selective modification of organic compounds in the presence of amines and/or sulfides | |
| Jia et al. | Catalytic oxidation of alcohols to aldehydes and ketones with ferric nitrate nonahydrate/trifluoroacetic acid via mechanochemical reaction | |
| US6878821B2 (en) | Modifying chemoselectivity during oxidation of nitrogen compounds | |
| Gonsalves et al. | 5, 10, 15, 20-Tetrakisaryl-and 2, 3, 7, 8, 12, 13, 17, 18-octahalogeno-5, 10, 15, 20-tetrakisarylporphyrins and their metal complexes as catalysts in hypochlorite epoxidations | |
| d'A et al. | Metalloporphyrin catalytic oxidations of hydrocarbons by H2O2 | |
| Beng et al. | Site-selective, catalytic, and diastereoselective sp 3 C–H hydroxylation and alkoxylation of vicinally functionalized lactams | |
| Jain et al. | [Bmim] BF4-immobilized rhenium-catalyzed highly efficient oxygenation of aldimines to oxaziridines using solid peroxides as oxidants | |
| Chen et al. | Theoretical guidance and feedback on the design, preparation, and efficient catalytic oxidation of novel imidazole-modified iron porphyrin catalysts | |
| CN119735549B (en) | A method for the synthesis of 3-nitropyrazole catalyzed by metalloporphyrin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20020311 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20020311;LT PAYMENT 20020311;LV PAYMENT 20020311;MK PAYMENT 20020311;RO PAYMENT 20020311;SI PAYMENT 20020311 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: WARNER-LAMBERT COMPANY LLC |
|
| 17Q | First examination report despatched |
Effective date: 20030325 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20050330 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1047428 Country of ref document: HK |